Latest Breaking News On - Research efforts are underway for follicular lymphoma - Page 1 : comparemela.com

Julie M. Vose, MD, MBA, discusses the investigation of tazemetostat vs placebo when given in combination with lenalidomide and rituximab in patients with relapsed/refractory follicular lymphoma in the phase 3 SYMPHONY-1 study.

Mildrede harrisJuliem voseUniversity of nebraska medical centerDivision of hematologyNebraska medical centerResearch efforts are underway for follicular lymphomaOnclive tv